Terrence Higgins Trust welcomes addition of PrEP to WHO's Essential Medicines List
Details of PrEP trial in England still yet to materialise.
Dr Michael Brady, Medical Director at Terrence Higgins Trust, said: “Today’s addition of pre-exposure prophylaxis, or PrEP, to the World Health Organisation's Essential Medicines List is yet further evidence for the need to make this vital HIV prevention tool available to people at risk of HIV here in the UK.
“By including PrEP in this list, WHO have reinforced the effectiveness of PrEP, and its essential role for global heath needs.
“Adding PrEP to our existing HIV prevention strategies, alongside condoms, treatment and regular testing, means we would have everything we need to bring an end to HIV transmission in the UK; where currently 17 people are newly diagnosed with HIV every day.
“Scotland recently made history by becoming the first country to announce it will make PrEP available on the NHS. Wales has also taken a momentous step forward by announcing a three year pilot that will reach those at risk of HIV. However in England, a long-awaited PrEP trial is still yet to materialise, six months after it was promised. We must not let PrEP become a postcode lottery – it should be available to all those at risk, as soon as possible, regardless of where they live.”